87 related articles for article (PubMed ID: 4048870)
21. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
[TBL] [Abstract][Full Text] [Related]
22. [Production and characterization of monoclonal antibodies directed against the hepatitis B surface antigen].
Pujol FH; Rodríguez I; Liprandi F
Acta Cient Venez; 1992; 43(4):235-9. PubMed ID: 1343738
[TBL] [Abstract][Full Text] [Related]
23. Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside.
Shouval D; Adler R; Wands JR; Hurwitz E
J Hepatol; 1986; 3 Suppl 2():S87-95. PubMed ID: 3036937
[TBL] [Abstract][Full Text] [Related]
24. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
25. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
26. Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide.
Waters J; Pignatelli M; Galpin S; Ishihara K; Thomas HC
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2467-73. PubMed ID: 2431101
[TBL] [Abstract][Full Text] [Related]
27. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen.
Maeda F; Nagatsuka Y; Ihara S; Aotsuka S; Ono Y; Inoko H; Takekoshi M
J Med Virol; 1999 Aug; 58(4):338-45. PubMed ID: 10421399
[TBL] [Abstract][Full Text] [Related]
28. A highly sensitive radioimmunoassay technique for subtyping the antibody to hepatitis B surface antigen.
Fang CT; Nath N; Berberian H; Dodd RY
J Immunol Methods; 1978; 24(3-4):371-5. PubMed ID: 722102
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies to hepatitis B surface antigen: production and characterization.
Hlozánek I; Dostálová V; Korec E; Zelený V; König J; Nĕmecek V
Folia Biol (Praha); 1986; 32(3):167-77. PubMed ID: 3527770
[TBL] [Abstract][Full Text] [Related]
30. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg).
Shin YW; Ryoo KH; Hong KW; Chang KH; Choi JS; So M; Kim PK; Park JY; Bong KT; Kim SH
Antiviral Res; 2007 Aug; 75(2):113-20. PubMed ID: 17343928
[TBL] [Abstract][Full Text] [Related]
31. [Preparation of human anti-HBs from volunteers with hepatitis B vaccine boost vaccination by modified B-cell immortalization technique].
Lou HB; Zhou YP; Zhou FY; Zhang MX; Wei JF; Zeng YL; Wang JJ; Wang YJ; Wu AH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):949-52. PubMed ID: 20501364
[TBL] [Abstract][Full Text] [Related]
32. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
[TBL] [Abstract][Full Text] [Related]
33. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen.
Shiraki K; Hayakawa Y; Mori H; Namazue J; Takamizawa A; Yoshida I; Yamanishi K; Takahashi M
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1393-9. PubMed ID: 1646279
[TBL] [Abstract][Full Text] [Related]
34. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
Xiang Y; Chen P; Xia JR; Zhang LP
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
[TBL] [Abstract][Full Text] [Related]
35. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
[TBL] [Abstract][Full Text] [Related]
36. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.
Barnaba V; Levrero M; Ruberti G; van Dyke A; Perrone A; Musca A; Balsano F
Clin Exp Immunol; 1987 Nov; 70(2):283-8. PubMed ID: 2962789
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human monoclonal antibodies directed against hepatitis B surface antigen.
Ehrlich PH; Moustafa ZA; Justice JC; Harfeldt KE; Kelley RL; Ostberg L
Hum Antibodies Hybridomas; 1992 Jan; 3(1):2-7. PubMed ID: 1374272
[TBL] [Abstract][Full Text] [Related]
38. Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.
Heijtink RA; van Bergen P; Paulij WP; de Man RA; Osterhaus AD
Vaccine; 2000 Feb; 18(15):1531-8. PubMed ID: 10618551
[TBL] [Abstract][Full Text] [Related]
39. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen.
Golsaz-Shirazi F; Amiri MM; Bahadori M; Bayat AA; Mohammadi H; Farid S; Maddah M; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Shokri F
Viral Immunol; 2015 Oct; 28(8):425-33. PubMed ID: 26425894
[TBL] [Abstract][Full Text] [Related]
40. [Development of recombinant human-derived IgG antibody against HBsAg].
Guo Y; Liang MF; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Jun; 18(2):105-8. PubMed ID: 15340493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
